Anergic human CLL is characterised by constitutive activation of the BCR signalling cascade11 while aggressive forms of the disease typically display an enhanced response to external BCR stimuli with consecutive stimulation of downstream targets6. Here, BCR is linked to B-cell chronic lymphocytic leukemia.